[Arrhythmias. 7. Treatment with beta-receptor blocking agents].
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000328:Adult; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D001145:Arrhythmias, Cardiac / Q000139:chemically induced / Q000188:drug therapy*; D001794:Blood Pressure / Q000187:drug effects; D004071:Digitalis Glycosides / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D006327:Heart Block / Q000188:drug therapy; D006329:Heart Conduction System / Q000187:drug effects; D006331:Heart Diseases / Q000188:drug therapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D009467:Neuromuscular Depolarizing Agents / Q000494:pharmacology; D011433:Propranolol / Q000008:administration & dosage; D011802:Quinidine / Q000494:pharmacology; D013565:Sympatholytics / Q000627:therapeutic use*
D000319:Adrenergic beta-Antagonists; D000889:Anti-Arrhythmia Agents; D004071:Digitalis Glycosides; D009467:Neuromuscular Depolarizing Agents; D013565:Sympatholytics; D011433:Propranolol; D011802:Quinidine
Hjärtarytmier. 7. Behandling med beta-receptorblockerare.